Senators Call for Review of ‘Ineffective’ FDA Recall Policies
Senators Durbin and Blumenthal have requested the Government Accountability Office (GAO) to review the FDA's policies on medical device recalls, citing the Philips Respironics case and a significant increase in recalls.